Companies: 49,246 Total Market Cap: 132386205533959.40

Leverage Shares 3X Long Moderna

LON-3MRN
Rank #48393
Market Cap 369,276.96
Volume 1,394
Price 798.76
Change (%) 16.83%
Country or region Ireland Ireland

Leverage Shares 3X Long Moderna's latest marketcap:

369,276.96

As of 05/20/2025, Leverage Shares 3X Long Moderna's market capitalization has reached $369,276.96. According to our data, Leverage Shares 3X Long Moderna is the 48393th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 369,276.96
Revenue (ttm) 0
Net Income (ttm) 0
Shares Out 40,000
EPS (ttm) 0
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date n/a
Market Cap Chart
Data Updated: 05/20/2025

Leverage Shares 3X Long Moderna's yearly market capitalization.

Leverage Shares 3X Long Moderna has seen its market value grow from £10,223 to £276,000 since 2022, representing a total increase of 2,599.79% and an annual compound growth rate (CAGR) of 297.19%.
Date Market Cap Change (%)
05/20/2025 £276,000 3827.63%
12/31/2024 £6,080 330.59%
09/07/2023 £1,412 -86.19%
12/30/2022 £10,223

Company Profile

Leverage Shares 3X Long Moderna (3MOD)

Product Overview: The Leverage Shares 3X Long Moderna ETP offers investors 3x leveraged exposure to the daily performance of Moderna, Inc. (MRNA). Designed for short-term trading, this product magnifies gains (or losses) relative to Moderna's stock movements.

Key Features:

  • 3X Daily Leverage: Seeks to deliver 3x the daily return of Moderna's stock price.
  • Short-Term Focus: Ideal for tactical traders due to compounding effects over time.
  • Liquidity: Trades on major exchanges like the London Stock Exchange (LSE).

Risk Note: Leveraged products carry heightened risk, including potential for rapid losses exceeding initial investment. Not suitable for long-term holdings or risk-averse investors.

Ticker: 3MOD (LSE) | Underlying: Moderna, Inc. (MRNA)

Frequently Asked Questions

As of 05/20/2025, Leverage Shares 3X Long Moderna (including the parent company, if applicable) has an estimated market capitalization of $369,276.96 USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Leverage Shares 3X Long Moderna global market capitalization ranking is approximately 48393 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Ireland
Founded 0
IPO Date n/a
Employees n/a
CEO
Sector
Industry
Address
Website